Letter: Skin cancer in albinos at the university of calabar teaching hospital, calabar, Nigeria

Dermatology Online Journal

Volumn 16, Issue 4, 2010, Pages

  Asuquo, M E ^a   Otei, O O ^a   Omotoso, J ^a   Bassey, E E ^a  

^a UNIVERSITY OF CALABAR   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOTOXIC ANTIBODY; METHOTREXATE;

ADULT; AGE; ALBINISM; CANCER CLASSIFICATION; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; NIGERIA; RISK FACTOR; SEX DIFFERENCE; SKIN CANCER; SKIN DEFECT; TEACHING HOSPITAL; TREATMENT OUTCOME; BASAL CELL CARCINOMA; MELANOMA; MIDDLE AGED; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ADULT; ALBINISM; CARCINOMA, BASAL CELL; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; NIGERIA; RISK FACTORS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 77953095777     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Letter

References (20)

1. Gross ND, Monroe M. Skin cancer: Squamous cell carcinoma updated Jan 15, 2009
2. Hahn SB, Kim DJ, Jeon CH. Clinical study of Marjolin's ulcer. Yousei Med J 1990; 31: 234-241.
3. Kromberg JG, Castle D, Zwane EM, Jenkins T. Albinism and skin cancer in Southern Africa. Clin. Genet 1989; 36(1): 43-52.
4. Yakubu A, Mabogunje OA. Skin cancer in African albinos. Acta Oncol. 1993: 32(6): 621-622.
5. Durham-Pierre D, Gardner JM, Nakatsu Y, King RA, Francke U, Ching A, Aquaron R, del Marmol V, Brilliant MH. African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism. Nat Genet 1994; 7(2): 176-179.
6. Kedda MA, Steorens G, Manga P, Viljoen C, Jenkins T, Ramsay M. The tyrosinase positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in south African negroids. Am J Hum Genet 1994; 54(6): 1078-1084.
7. Spritz RA, Fukai K, Holmes SA, Luande J. Frequent intragenic deletion of the P gene in Tanzanian patients with type11 oculocutaneous albinism (OCA2). Am J Hum Genet 1995; 56(6): 1320-1323.
8. Hong ES, Zeeb H, Repacholi MH. Albinism in Africa as a public health issue. BMC Public Health. 2006; 6: 212.
9. Datubo-Brown D D. Primary malignant skin tumours in Nigerians. J. Natl. Med Assoc. 1991 Apr; 83(4): 345-348.
10. Yakubu A, Mabogunje O A. Skin Cancers in Zaria. Trop. Doct. 1995; 25 suppl. 1: 65-67.
11. Glanz K, Saraiya M. Using evidence-based community behavioural interactions to prevent skin cancer. Opportunities and challenges for Public Health Practice. Prev Chronic Dis 2005 April 2(2)
12. Aquaron R. Oculocutaneous albinism in Cameroon. A 15-year follow up study. Ophthalmic Paediatr Genet 1990; 11(4): 255-263.
13. Ademiluyi S A, Ijaduola G T. Occurrence and recurrence of BCC of the head and neck in Negroid and Albinoid Africans. J. Laryngol Otol. 1987 Dec; 101(12): 1324-11328.
14. Terenziani M, Spreafico F, Serra A, Poddam M, Cereda S, Belli F. Amelanotic melanoma in a child with oculocutaneous albinism. Med Paediatr Oncol 2003; 4: 179-180.
15. George AO, Ogunbiyi AO, Daramola OOM, Campbell OB. Albinism among Nigerians with malignant melanoma. Trop Doc 2005; 35: 55-56.
16. Luande J, Henschke CI, Mohammed N. The Tanzanian human albino skin. Natural history. Cancer 1985; 55(8): 1823-1828.
17. Colebunders R, Bottieau E, Van den Brande J, Colpaert C, Van Marck E. Merkel cell carcinoma and multiple basal cell carcinoma in an African albino woman with HIV infection. HIV Med. 2004; 5(6): 452-454.
18. Efem SEE. Clinical observations of wound healing properties of homey Br J Surg 1988; 75: 679-681.
19. Lookingbill DP, Lookingbill GL, Leppard B. Active damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an outreach skin care programme. J Am Acad Dermatol 1995; 32(4): 653-658.
20. Okoro AN. Albinism in Nigeria. A clinical and social study. Br J Dermatol 1975; 92(5): 485-492.